Related Experiment Video
Updated: Aug 19, 2026

Detecting the Ligand-binding Domain Dimerization Activity of Estrogen Receptor Alpha Using the Mammalian Two-Hybrid Assay
Published on: December 19, 2018
[Antiaggregant and antioxidant activity of estradiol and tamoxifen]
Abstract:
Tamoxifen did not influence the human platelet aggregation in vitro, while estradiol at a concentration of 10(-6) M inhibited the aggregation of human thrombocytes induced by ADP, serotonin + adrenaline, and adrenaline (epinephrine) by 14.7, 12.5, and 16.6%, respectively. Estradiol introduced in the range of effective concentrations from 10(-8) to 10(-4) M inhibited lipid peroxidation, while tamoxifen produced this effect only at a concentration of 10(-4) M. There was a correlation between the antiaggregant activity and antioxidant properties of estradiol.
Related Concept Videos
Drug-Receptor Interaction: Antagonist
Antagonists can be classified as competitive or noncompetitive based on their...
Combined Effects of Drugs: Antagonism
The most common type is receptor antagonism, where one drug acts as an antagonist to block the effects of another drug by...
Adrenergic Agonists: Chemistry and Structure-Activity Relationship
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of the aromatic...
Masking and Demasking Agents
There are many masking agents, such as cyanide, fluoride, triethanolamine, thiourea, and 2,3-bis(sulfanyl)propan-1-ol (formerly 2,3-dimercapto-1-propanol), with the masking agent chosen based on the metal...
Antidepressant Drugs: MAOIs and Other Agents
Agonism and Antagonism: Quantification
To quantify these effects, researchers use a dose-response curve, which provides valuable information about the potency and efficacy of a drug. Potency refers to...

